Technology News and Research

RSS

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

...

15 Oct 2013

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy is a surprisingly prevalent problem. Something like 27% of the U.S. population and 20% of the European population are what’s called skin-prick test positive for house dust mites, which is a test for sensitivity to allergens to find out if a person is likely to get that allergy.

15 Oct 2013

New injection device to reduce fear and pain of injecting modern medicines

...

15 Oct 2013

Astrazeneca Acquires Spirogen For Up To $440M

...

15 Oct 2013

First Edition: October 15, 2013

Today's headlines include reports about how the budget deal taking shape in the Senate would not derail the health law, but would include some tweaks.

15 Oct 2013

Voxiva's personalized interactive smoking cessation program shows early success

Voxiva, Inc., a pioneer in interactive mobile health programs, has announced that Text2quit, their personalized interactive smoking cessation program, is showing early success across the country.

15 Oct 2013

Colorcon, Evonik partner to market and support Acryl-EZE aqueous acrylic enteric system

Colorcon and Evonik have announced the signing of a cooperation agreement for the market promotion and technical support of Acryl-EZE, aqueous acrylic enteric system.

15 Oct 2013

St. Jude Medical completes Nanostim acquisition; leadless pacemaker receives CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced the completion of its acquisition of Nanostim, Inc., a privately-owned developer of miniaturized, leadless pacemakers.

15 Oct 2013

Tepnel Pharma Services uses Hologic’s Invader Plus technology to offer genotyping, CNV service

Tepnel Pharma Services, a division of Hologic, Inc., is now using Hologic’s proprietary Invader and Invader Plus technology as part of its Molecular Genetic Services offering, enabling it to offer customers a more cost effective and high throughput genotyping and copy number variation service.

From Hologic, Inc. 15 Oct 2013

Promising new type of cancer treatment to benefit more patients

More patients than ever stand to benefit from a promising new type of cancer treatment, after scientists compiled a library of molecules that can prime patients’ immune systems to fight a range of cancers including leukaemia, myeloma, lung cancer and skin cancer.

15 Oct 2013

Viewpoints: Marketplaces' 'technical foibles' may keep young people from coming back; health law may be ushering in era of narrow networks

The encouraging view is that the overwhelming number of visitors to the site indicates high demand for insurance in the new system. That's critical, because the more people who participate, the better the system works. The danger is that the technical foibles since Oct. 1 will discourage people from coming back, particularly the young and healthy customers the system needs to keep rates reasonable. With some big deadlines approaching, the Obama administration needs to fix the bugs, and fast. People who need insurance from the federal marketplace have until mid-December to buy coverage that begins Jan. 1. If enrollment figures aren't robust by then, the new health-care system will have a problem even bigger than a frustrating Web (10/11).

15 Oct 2013

Modeling, identifying predictors of Parkinson's disease with stem cells

The New York Stem Cell Foundation Research Institute has entered into a partnership with the Parkinson's Progression Markers Initiative to build resources for studying Parkinson's disease to accelerate new treatments. Sponsored by The Michael J. Fox Foundation for Parkinson's Research, PPMI is a landmark effort to identify and validate biomarkers of Parkinson's disease.

15 Oct 2013

Experts worry about other trouble spots with health law marketplaces

Politico reports that other steps in the online enrollment process, including computing subsidies and transferring signup information to insurers may also have bugs. The Associated Press reports that some insiders predicted the problems well before the website launch, while The Washington Post notes that paper applications are increasingly popular because of the problems.

15 Oct 2013

FDA approves OTREXUP injection for adults with RA, children with active pJIA

Antares Pharma, Inc. today announced the approval of OTREXUP (methotrexate) injection by the U.S. Food and Drug Administration. OTREXUP is the first FDA approved subcutaneous methotrexate for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

14 Oct 2013

First Edition: October 14, 2013

Today's headlines include the latest on the budget negotiations as well as examinations of what's happening with the health law's online insurance marketplaces.

14 Oct 2013

BioInvent extends license agreement with Bayer to develop antibodies

BioInvent International AB today announces that it has signed an extension to its 2008 license agreement with Bayer Pharma AG for the development of antibodies from BioInvent's n-CoDeR libraries.

14 Oct 2013

Researchers discover new approach to tackle global threat of antibiotic drug resistance

Researchers at McMaster University are addressing the crisis in drug resistance with a novel approach to find new antibiotics.

13 Oct 2013

Rutgers getting ready to launch solution to deliver more effective care at lower cost

During nearly three decades as a primary care physician, Alfred Tallia has identified a daunting list of flaws with the nation's health care.

13 Oct 2013

Use of iPad for educational purposes increases among Millennial residents

With the entry of "Millenials" into medical residency programs across the country, institutions have started to examine ways to improve programs to correspond with that generation's learning behaviors and preferences.

13 Oct 2013

Blame for Healthcare.gov's problems placed on key design element

As outside experts offered opinions about the reasons for the glitches in the federal health insurance exchange, administration officials asked consumers for patience while the system undergoes repairs. Meanwhile, House and Senate Republicans launched investigations into the difficulties.

12 Oct 2013

Technology News and Research

CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As Potential HPV Treatment

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

New injection device to reduce fear and pain of injecting modern medicines

Astrazeneca Acquires Spirogen For Up To $440M

First Edition: October 15, 2013

Voxiva's personalized interactive smoking cessation program shows early success

Colorcon, Evonik partner to market and support Acryl-EZE aqueous acrylic enteric system

St. Jude Medical completes Nanostim acquisition; leadless pacemaker receives CE Mark approval

Tepnel Pharma Services uses Hologic’s Invader Plus technology to offer genotyping, CNV service

Promising new type of cancer treatment to benefit more patients

Viewpoints: Marketplaces' 'technical foibles' may keep young people from coming back; health law may be ushering in era of narrow networks

Modeling, identifying predictors of Parkinson's disease with stem cells

Experts worry about other trouble spots with health law marketplaces

FDA approves OTREXUP injection for adults with RA, children with active pJIA

First Edition: October 14, 2013

BioInvent extends license agreement with Bayer to develop antibodies

Researchers discover new approach to tackle global threat of antibiotic drug resistance

Rutgers getting ready to launch solution to deliver more effective care at lower cost

Use of iPad for educational purposes increases among Millennial residents

Blame for Healthcare.gov's problems placed on key design element

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News